Raymond James Boosts DexCom (NASDAQ:DXCM) Price Target to $1

DexCom (NASDAQ:DXCM – Free Report) had its target price lifted by Raymond James from $147.00 to $151.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a strong-buy rating on the medical device company’s stock. A number of other research analysts have also commented on DXCM. Piper Sandler upped their price target […]

Related Keywords

United States , Washington , Raymond James , Steven Robert Pacelli , Piper Sandler , Leerink Partnrs , Washington Trust Advisors Inc , Valley National Advisers Inc , Harbour Investments Inc , Dexcom Company Profile , Jpmorgan Chase Co , Citigroup , Bartlett Co , Nasdaq , Atlas Capital Advisors , Dexcom Inc , Securities Exchange Commission , Wells Fargo Company , Free Report , Moderate Buy , Com Stock Down , Get Free Report , Director Steven Robert Pacelli , Exchange Commission , National Advisers , Capital Advisors , Washington Trust Advisors , Trust Advisors , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Boost Price Target ,